Bio-IT World July 16, 2024
Deborah Borfitz

Artificial intelligence (AI) is the new frontier in biomedical research, with large language models changing the way science is done from writing code and brainstorming research ideas to helping do research and conducting literature reviews. In some of its latest applications, generative AI has been used in designing molecules with insights produced at a scale and speed not possible with traditional deep learning methods alone, according to Marinka Zitnik, Ph.D., assistant professor of biomedical informatics at Harvard Medical School.

The potential of AI to aid in the development of new drugs to cure disease is enormous given the size of the chemical universe (1060 chemical compounds) relative to the tiny fraction (105) that has been synthesized...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma / Biotech, Technology, Trends
Closing the women’s health gap: Biopharma’s untapped opportunity
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Four Opportunities To Revitalize The US Biomedical Research Enterprise
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

Share This Article